Alembic Pharmaceuticals is currently trading at Rs. 69.90, up by 2.15 points or 3.17% from its previous closing of Rs. 67.75 on the BSE.
The scrip opened at Rs. 67.95 and has touched a high and low of Rs. 71.00 and Rs. 67.85 respectively. So far 51754 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 74.25 on 27-Aug-2012 and a 52 week low of Rs. 34.00 on 06-Jan-2012.
Last one week high and low of the scrip stood at Rs. 74.25 and Rs. 64.95 respectively. The current market cap of the company is Rs. 1307.36 crore.
The promoters holding in the company stood at 74.13% while Institutions and Non-Institutions held 7.62% and 18.25% respectively.
Alembic Pharmaceuticals has restored the major part of the manufacturing operations at the company's Panelav API-1, Manufacturing Unit located at Gujarat. The work for restoration of balance portion is going on and is expected to be completed in another one week.
The fire had broke out at the company’s API 1 plant located at Panelav, Gujarat in solvent recovery area on August 26, 2012.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |